The binding nature of mibolerone in cytosols and nuclear extracts from hypertrophic human prostate was examined in comparison with that of R 1881.
The binding nature of mibolerone in cytosols and nuclear extracts from hypertrophic human prostate was examined in comparison with that of R 1881. The binding of mibolerone in the cytosol and nuclear extract was single and of high affinity when evaluated by the method of Scatchard (1949) . Binding of mibolerone with testosterone-binding globulin was not detected. The sedimentation coefficients of the binder for mibolerone in the cytosol and nuclear extract were 10.6S and 3.6S, respectively.
When triamcinolone acetonide was induced in the binding medium, inhibition of mibolerone binding in the cytosol by testosterone and dihydrotestosterone was potentiated and this may imply that the binding observed in the presence of triamcinolone acetonide was responsible for the binding of the androgen roceptor.
In the nuclear extract, the binding was attributable mainly to the androgen receptor irrespective of the presence or absence of triamcinolone acetonide.
These properties of the binding observed in the hypertrophic human prostate were almost same as those of the binding with R 1881.
Although maximum binding sites measured using mibolerone were correlated with those using R 1881 in the cytosols as well as in the nuclear extracts, the values obtained with mibolerone were slightly greater than those with R 1881. Thus, mibolerone seems to be a suitable ligand for measuring the androgen receptor, but when compared with R 1881 no special merits in using mibolerone were detected.
It has been accepted that normal and pathological human prostates contain the androgen receptor which may mediate the androgen action in these tissues (Menon et al., 1977; Shain and Boesel, 1978) . Measurement of the androgen receptor in the human prostate seems to be valuable in basic and clinical studies, since the presence of estrogen receptor in mammary tumors is an apparent indicator of the response of the tumors to endocrine therapies (Nomura et al., 1977) , and an analogous effect may be expected in the case of prostatic cancer. However, there exist many proteins which interfere with the measurement of androgen receptor in the human prostate.
For this reason, several improvements in the estimation of androgen receptor to avoid any binding caused by interfering proteins have appeared (Ghanadian and Auf, 1982 
Results
Binding, of 3H-mibolerone and 3H-R 1881 to cytosols from hypertrophic human prostate To examine the effect of incubation time on the binding of 3H-mibolerone, the cytosol was incubated for various time periods in the presence or absence of triamcinolone acetonide (Fig. 1) . The binding reached a near plateau by 18h after the start of the incubation.
The presence of triamcinolone acetonide did not modify the time course of the binding.
Therefore, subsequent incubations with 3H-mibolerone were performed for 18 h.
The binding of 3H-mibolerone to the cytosol showed a single high affinity pattern (Fig. 2) .
The addition of triamcinolone acetonide reduced Bmax by approximately 50% and Kd was diminished to some extent. Binding sites for 3H-R 1881 in the same cytosol were smaller than those for 3H-mibolerone (Fig. 2) . The effect of triamcinolone acetonide on the binding of 3H-R 1881 was also noticed.
Although 3H-dihydrotestosterone showed was observed at the site of 10.6S, and this site was identical to that prelabeled with 3H-R 1881 (data not shown).
To examine the effect of various steroids on the binding of 3H-mibolerone, the cytosol was incubated with 1nM 3H-mibolerone supplemented various concentrations (10-1,000nM) of additives (Fig. 5) . R 1881 was a potent inhibitor of the binding and the rate of inhibition by R 1881 was the same two ligands. The addition of triamcinolone acetonide did not modify the binding of these two ligands to the nuclear extract (data not shown).
The nuclear extract prelabeled with 5nM 3H-mibolerone was fractionated in a sucrose density gradient centrifugation (Fig. 7) . A radioactive peak of 3H-mibolerone was detected at the site corresponding to 3.6S, Fig. 8 and this site was also observed in the binding of 3H-R 1881 to the nuclear extract (data not shown).
The effect of the addition of various steroids on the binding of 3H-mibolerone to the nuclear extract was examined (Fig. 8) . Potent inhibition of an almost identical degree to the binding was noticed following the addition of R 1881, mibolerone or dihydrotestosterone, but a supplement of triamcinolone acetonide to the incubation mixture did not show any effect on the binding.
Therefore, the binding of 3H-mibolerone to the nuclear extract may be mainly attributable to the androgen receptor, and this was quite analogous to the binding of 3H-R 1881 to the nuclear extract (Kodama et al., 1980) .
Comparison of the binding of 3H-mibolerone with that of 3H-R 1881 to androgen receptor
The binding of 3H-mibolerone and 3H-R 1881 to the cytosol and the nuclear extract from the hypertrophic human prostates was examined simultaneously by saturation analysis, and the binding parameters were compared (Table 1) . The Kd's of these two ligands were almost identical. The Bmax for these ligands correlated well in both cytosols and nuclear extracts (Fig. 9) , but the values obtained with 3H-mibolerone were somewhat higher than those with 3H-R 1881 in both cytosols and nuclear extracts. 
Discussion
Although the human prostate contains testosterone-binding protein which may be derived from the blood plasma (Cowan et al., 1976; Dennis et al., 1977; Mobbs et al., 1977) , R 1881 does not bind with this protein (Bonne and Raynaud, 1976; Ghanadian et al., 1978) . This is one of the advantages in using R 1881 to examine the androgen receptor in human samples, and the use of this ligand for quantitative determination of the androgen receptor has been stressed. In the present study, no significant binding of mibolerone to the testosterone-binding globulin was observed as is noticed with R 1881. On the other hand, the disadvantage of applying R 1881 to measure the androgen receptor is due to the fact that this ligand binds to progestinbinding component(s) in addition to the androgen receptor in the human prostate (Menon et al., 1978) . It was reported by Zava et al. (1979) and Asselin et al. (1978) that the addition of triamcinolone acetonide inhibited the binding of R 1881 with progestin-binding component(s), thereafter measurement of the androgen receptor in the human prostate has been performed with this ligand in the presence of triamcinolone acetonide (Hicks and Walsh, 1979; Trachtenberg et al., 1981 Trachtenberg et al., , 1982 Shain et al., 1980; Ekman et al., 1982; Wilbert et al., 1983) . In the present study, it is revealed in the inhibition experiments that mibolerone also binds not only to the androgen receptor but also to other binding components, being almost identical to the binding observed in R 1881 (Shimazaki et al., 1981) . Moreover, Kd for the binding with mibolerone is larger than that for R 1881, and this suggests that mibolerone binds to more nonspecific binders than R 1881 (Fig. 2, mibolerone reveals a single binding which seems to be due to the androgen receptor. Therefore, the binding specificity of mibolerone is considered to be almost identical to that of R 1881.
The maximum binding sites of the androgen receptor obtained from the incubation with mibolerone are slightly larger than those of R 1881. The reason for this differe nces in the maximum binding sites of these two ligands has not been fully elucidated.
However, one possible explanation is that the rate of exchange of preoccupied androgen receptors by 3H-mibolerone is higher than that by 3H-R 1881, since the binding affinity of mibolerone is higher than that of other androgens including R 1881 (Liao et al., 1973) . Although the present experiments show almost identical Kd for mibolerone and R 1881 in the binding with androgen receptor, preliminary experiments on the rate of exchange of the preoccupied cytosolic androgen receptor showed more than 80% by mibolerone, and this seems to be slightly more effective than by R 1881 (Nozumi et al., 1981) . Alternatively, the higher stability of mibolerone may explain the higher maximum binding sites, since R 1881 is relatively unstable due to photolability (Randail and Mainwaring, 1984) . From these results, it may be concluded that mibolerone is a suitable ligand for determination of androgen receptors, but the binding properties of this ligand are almost the same as those of R 1881 and the distinct superiority of this ligand over R 1881 is not proved. The binding parameters with mibolerone in the hypertrophic human prostates obtained in this study are in the same range to those examined as androgen receptor by others (Ekman et al., 1979; Ghanadian and Auf, 1982; Sirett and Grant, 1982; Barrack et al., 1983; Hernandez et al., 1983) .
When R 5020, a specific ligand for the progestin receptor, and cytosol of the human prostate are incubated, a considerable amount of high affinity binding has been observed (Gustafsson et al., 1978) . From the similarity in steroid specificity, binding parameters and sedimentation coefficient between the progestin receptor in the uterus and the binder for R 5020 in the human prostate, it has been suggested that the binder of the human prostate is the progestin receptor per se (Bashirelahi et al., 1983ab; Schneider et al., 1984) . However, we previously claimed that the progestin-binding component (s) in the human prostate is not the progestin receptor, since the nuclear extract of the human prostate does not bind with R 5020 (Kodama et al., 1981) . Although R 1881 binds to the progestin receptor in a high affinity, it was reported by Wilks et al. (1980) that the binding affinity of mibolerone to the uterine progesterone receptor of hamster is relatively low. Together with the results of the present finding that triamcinolone acetonide almost equally inhibits the bindings of mibolerone and R 1881, it seems to be quite unlikely that the progestin-binding component (s) in the hypertrophic human prostate is the progestin receptor. However, at variance with the observation of Wilks et al. (1980) , Delettre et al. (1980) reported that the binding of the progestin receptor in uterine cytosol of rabbit to mibolerone is of high affinity and is not different from that to R 1881.
For accurate determination of steroid hormone receptors, it seems to be ideal to use a ligand which is specific to individual receptor.
Unfortunately it is revealed that mibolerone is not specific to the androgen receptor of the human prostate. Further studies to explore more suitable ligands for the androgen receptor will be awaited.
